[go: up one dir, main page]

RU2001119471A - USE OF RILUZOL IN THE TREATMENT OF ACOUSTIC INJURIES - Google Patents

USE OF RILUZOL IN THE TREATMENT OF ACOUSTIC INJURIES

Info

Publication number
RU2001119471A
RU2001119471A RU2001119471/14A RU2001119471A RU2001119471A RU 2001119471 A RU2001119471 A RU 2001119471A RU 2001119471/14 A RU2001119471/14 A RU 2001119471/14A RU 2001119471 A RU2001119471 A RU 2001119471A RU 2001119471 A RU2001119471 A RU 2001119471A
Authority
RU
Russia
Prior art keywords
injuries
treatment
acoustic
preparation
riluzol
Prior art date
Application number
RU2001119471/14A
Other languages
Russian (ru)
Inventor
Жан-Мари ШТУТЦМАНН
Джон РЕНДЛ
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of RU2001119471A publication Critical patent/RU2001119471A/en

Links

Claims (6)

1. Применение рилузола или одной из его фармацевтически приемлемых солей для приготовления лекарственных средств, предназначенных для предотвращения и/или лечения акустических травм.1. The use of riluzole or one of its pharmaceutically acceptable salts for the preparation of medicines intended to prevent and / or treat acoustic injuries. 2. Применение по п. 1 для приготовления лекарственных средств, предназначенных для предотвращения и/или лечения шума в ушах. 2. The use according to claim 1 for the preparation of medicines intended to prevent and / or treat tinnitus. 3. Применение по п. 1 для приготовления лекарственных средств, предназначенных для предотвращения и/или лечения глухоты. 3. The use according to claim 1 for the preparation of medicines intended to prevent and / or treat deafness. 4. Применение по п. 3 для предотвращения и/или лечения глухоты, обусловленной звуковыми травмами. 4. The use of claim 3 for the prevention and / or treatment of deafness due to sound injuries. 5. Применение по п. 3 для предотвращения и/или лечения глухоты, обусловленной возрастом. 5. The use according to claim 3 for the prevention and / or treatment of age-related deafness. 6. Применение по одному из пп. 1-5 для приготовления лекарственного средства, содержащего от 25 до 200 мг рилузола. 6. The use according to one of paragraphs. 1-5 for the preparation of a medicinal product containing from 25 to 200 mg of riluzole.
RU2001119471/14A 1998-12-15 1999-12-13 USE OF RILUZOL IN THE TREATMENT OF ACOUSTIC INJURIES RU2001119471A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR98/15834 1998-12-15

Publications (1)

Publication Number Publication Date
RU2001119471A true RU2001119471A (en) 2003-04-20

Family

ID=

Similar Documents

Publication Publication Date Title
IL143512A (en) Azabicycloalkanes, pharmaceutical compositions comprising same and use thereof for the manufacture of medicaments for the prevention or treatment of infection by immunodeficiency virus
EP1600168A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder
FI925342A0 (en) Process for the preparation of therapeutically active (+) - - (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinemethanol
EP1029540A3 (en) Use of droloxifene for the treatment of cardiovascular diseases
DK0503440T3 (en) Sumatriptan-containing medicines
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
CA2189916A1 (en) A new regime for paclitaxel in kaposi's sarcoma patients
EP1440691A3 (en) Treatment of neurotic disorders
EP2138175A3 (en) Formulations comprising valsartan for treating diabetes or microalbuminuria
RU2001124802A (en) The use of saredutant and its pharmaceutically acceptable salts for the preparation of medicines used to treat or prevent mood disorders, adaptation disorders or mixed anxiety-depressive disorders
EP0657167A3 (en) Use of oenotheine B for the manufacture of a medicament for the treatment of disorders related to hyperandrogenism, pharmaceutical compositions containing oenotheine B and a process for its preparation from epilobium parviflorum.
RU2002122084A (en) COMBINATION OF MEDICINES, INCLUDING MIRTAZAPINE, FOR THE TREATMENT OF DEPRESSION AND RELATED DISORDERS
TR200102512T2 (en) The use of saredutan and its pharmaceutically acceptable salts for the preparation of medicinal products useful in the treatment or prevention of all mental disorders, adaptation disorders and various anxiety-depression disorders.
DE60026491D1 (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
DE69939075D1 (en) Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus
CA2217513A1 (en) Pharmaceutical agents for the treatment of alzheimer's disease
RU2002124141A (en) APPLICATION OF MIRTAZAPINE FOR TREATMENT OF SLEEP DISORDERS
RU2001119471A (en) USE OF RILUZOL IN THE TREATMENT OF ACOUSTIC INJURIES
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
RU2004112422A (en) ROUVASTATIN IN PREDEDENTIONAL CONDITIONS
RU97104062A (en) APPLICATION OF SELEGYLIN FOR TREATMENT OF EPILEPTIC DISEASES
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases
FR2673105B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS, ESPECIALLY FOR THE TREATMENT OF FUNCTIONAL COLOPATHIES, AND METHODS OF PREPARING COMPOSITIONS AND MEDICAMENTS, ESPECIALLY FOR THE TREATMENT OF THESE CONDITIONS.
ATE464051T1 (en) COMBINATION OF LEVOSIMENDAN AND A CALCIUM SOURCE FOR THE TREATMENT OF HEART FAILURE
HU9502320D0 (en) Use of inhibitors of ornitine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease and process to prepare (2s,5s)-5-fluoromethylornithine